MEET SARAH —

​SARAH SPENCER

​Sarah Spencer is a seasoned communications executive with over 25 years of experience in the biotech, pharmaceutical, and healthcare sectors. Most recently she served as Vice President of Corporate Communications and Investor Relations at Vor Bio, where she led all external and internal communications strategies for the NASDAQ-listed cell and genome engineering company. In this role, she has been instrumental in supporting major financing events, rebuilding the company’s brand messaging and website, and leading employee engagement initiatives across the organization.

​Previously, Sarah was Vice President of Corporate Communications at Audentes Therapeutics, where she led communications through its $3 billion acquisition by Astellas and the company’s integration thereafter. She also spent over a decade at GlaxoSmithKline (GSK) in roles of increasing responsibility, including Acting Vice President of U.S. Communications, and Director of Global Corporate Media. While at GSK, she led communications for business-critical initiatives such as M&A, financial results, regulatory issues, and international crises.

​Sarah began her career in public relations at Rite Aid Corporation and held leadership roles at Elan Pharmaceuticals and Berry & Company Public Relations. She holds a B.A. in Communication and Psychology from the State University of New York at Buffalo.